MedTrace Logo

Deep Friction Massage: Symptomatic

NCT03255538 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-03-07

No results posted yet for this study

Summary

Despite DFM being a widely-used technique and the empirical grounding regarding the importance of the pressure applied, there is no study characterizing the pressure applied during DFM, remaining it a discretion of the physiotherapist. Additionally, it is not known how the amount of pressure applied may influence pain mechanisms or function in the symptomatic patellar tendon. Having this, our objective is to characterize the pressure applied during deep friction massage and evaluate the immediate effects of different pressures applied during deep friction massage in the time until analgesia as well as in function, in patellar tendinopathy.

Conditions

  • Tendinopathy

Interventions

OTHER

DFM: Mean pressure

Deep friction massage as described by Dr. James Cyriax, performed with the mean pressure previously obtained in a baseline assessment.

OTHER

DFM: Mean pressure - 25%

Deep friction massage as described by Dr. James Cyriax, performed with the mean pressure previously obtained in a baseline assessment decremented by 25%.

OTHER

DFM: Mean pressure + 25%

Deep friction massage as described by Dr. James Cyriax, performed with the mean pressure previously obtained in a baseline assessment incremented by 25%.

Sponsors & Collaborators

  • Cooperativa de Ensino Superior, Politécnico e Universitário

    lead OTHER

Principal Investigators

  • Maria A Paço, PhD · Cooperativa Ensino Superior Politécnico e Universitário

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-21
Primary Completion
2017-11-20
Completion
2017-11-20

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03255538 on ClinicalTrials.gov